A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

BMY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.09%

Insider Buying (Last 12 Months): $672,994.06

Insider Selling (Last 12 Months): $4,525,215.08

Bristol-Myers Squibb Insider Trading History Chart

Bristol-Myers Squibb Share Price & Price History

^$49.00

▼ -0.14 (-0.28%)

As of 04/23/2024 01:00 AM ET

Days: 30 | 90 | 365

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Bristol-Myers Squibb Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2023	Christopher S. Boerner	CEO	Buy	2,000	$49.78	$99,560.00	82,672
11/28/2023	Christopher S. Boerner	CEO	Buy	3,071	$48.86	$150,049.06	79,384
11/20/2023	Theodore R. Samuels, II	Director	Buy	8,500	$49.81	$423,385.00	35,500
8/24/2023	Ann Powell	EVP	Sell	17,986	$61.25	$1,101,642.50	27,868
8/3/2023	Robert M. Plenge	EVP	Sell	732	$61.14	$44,754.48	6,584
5/3/2023	Rupert Vessey	EVP	Sell	50,385	$67.06	$3,378,818.10	47,751
2/6/2023	Ann Powell	EVP	Sell	11,183	$74.69	$835,258.27	23,043
2/6/2023	Giovanni Caforio	CEO	Sell	240,000	$74.65	$17,916,000.00	236,104
11/9/2022	Ann Powell	EVP	Sell	16,250	$80.45	$1,307,312.50	34,226
11/7/2022	Rupert Vessey	EVP	Sell	45,910	$78.88	$3,621,380.80	57,079
9/20/2022	Giovanni Caforio	CEO	Sell	25,000	$69.71	$1,742,750.00	476,104
9/15/2022	Giovanni Caforio	CEO	Sell	50,000	$71.84	$3,592,000.00	501,104
9/14/2022	Ann Powell	EVP	Sell	25,000	$70.75	$1,768,750.00	50,476
9/13/2022	David V. Elkins	CFO	Sell	133,951	$71.30	$9,550,706.30	100,460
6/13/2022	Giovanni Caforio	CEO	Sell	30,000	$74.04	$2,221,200.00	551,104
6/6/2022	Sandra Leung	EVP	Sell	65,000	$74.89	$4,867,850.00	308,627
3/21/2022	Giovanni Caforio	CEO	Sell	25,000	$71.52	$1,788,000.00
3/16/2022	Rupert Vessey	EVP	Sell	74,559	$69.25	$5,163,210.75
3/14/2022	Christopher S. Boerner	EVP	Sell	29,532	$69.20	$2,043,614.40
3/14/2022	Karen Murphy Santiago	SVP	Sell	6,577	$69.19	$455,062.63
2/24/2022	Giovanni Caforio	CEO	Sell	30,000	$67.00	$2,010,000.00
11/24/2021	Paul von Autenried	EVP	Sell	17,353	$56.92	$987,732.76
11/22/2021	Paul von Autenried	EVP	Sell	18,363	$57.17	$1,049,812.71
9/20/2021	Giovanni Caforio	CEO	Sell	25,000	$60.64	$1,516,000.00
8/12/2021	David V. Elkins	CFO	Sell	99,691	$66.95	$6,674,312.45
5/10/2021	Joseph Eid	SVP	Sell	1,118	$65.00	$72,670.00	8,069
5/10/2021	Louis S Schmukler	EVP	Sell	15,000	$65.25	$978,750.00	31,956
5/5/2021	Adam Dubow	SVP	Sell	3,119	$64.21	$200,270.99	16,243
5/5/2021	Rupert Vessey	EVP	Sell	30,546	$64.29	$1,963,802.34	45,139

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Bristol-Myers Squibb (NYSE:BMY)

76.41% of Bristol-Myers Squibb stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bristol-Myers Squibb Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	IRON Financial LLC	13,530	$0.73M	0.4%	+29.2%	0.001%
4/23/2024	Bell Bank	26,528	$1.44M	0.1%	+8.0%	0.001%
4/23/2024	Muhlenkamp & Co. Inc.	135,045	$7.32M	2.1%	+2.5%	0.007%
4/23/2024	Iowa State Bank	39,955	$2.17M	0.5%	-31.5%	0.002%
4/23/2024	Canal Capital Management LLC	107,340	$5.82M	1.0%	+91.6%	0.005%
4/23/2024	Busey Bank	211,097	$11.45M	0.4%	+1.5%	0.010%
4/23/2024	BSW Wealth Partners	8,251	$0.45M	0.1%	-7.3%	0.000%
4/23/2024	Sky Investment Group LLC	21,788	$1.18M	0.2%	-13.3%	0.001%
4/23/2024	Bfsg LLC	1,120	$61K	0.0%	+24.4%	0.000%
4/23/2024	Eads & Heald Wealth Management	20,531	$1.11M	0.5%	-15.5%	0.001%
4/23/2024	Global Retirement Partners LLC	20,045	$1.09M	0.0%	+1.7%	0.001%
4/23/2024	Cornell Pochily Investment Advisors Inc.	11,055	$0.60M	0.2%	-6.1%	0.001%
4/23/2024	Covenant Asset Management LLC	3,857	$0.21M	0.0%	-77.1%	0.000%
4/23/2024	LaFleur & Godfrey LLC	51,490	$2.79M	0.4%	+22.4%	0.003%
4/23/2024	Satovsky Asset Management LLC	5,180	$0.28M	0.1%	-15.3%	0.000%
4/23/2024	Louisiana State Employees Retirement System	118,400	$6.42M	0.1%	-3.7%	0.006%
4/23/2024	Sage Mountain Advisors LLC	4,974	$0.27M	0.0%	N/A	0.000%
4/23/2024	Moody Lynn & Lieberson LLC	50,469	$2.74M	0.2%	-79.7%	0.002%
4/23/2024	WASHINGTON TRUST Co	15,180	$0.82M	0.0%	-1.8%	0.001%
4/23/2024	Venturi Wealth Management LLC	1,211	$66K	0.0%	+38.2%	0.000%
4/23/2024	Live Oak Private Wealth LLC	6,529	$0.35M	0.1%	-4.4%	0.000%
4/23/2024	Community Financial Services Group LLC	74,986	$4.07M	0.9%	N/A	0.004%
4/23/2024	Cherry Creek Investment Advisors Inc.	10,329	$0.56M	0.3%	-59.0%	0.001%
4/23/2024	Amalgamated Bank	422,183	$22.90M	0.2%	-14.6%	0.021%
4/23/2024	Hall Laurie J Trustee	610	$33K	0.0%	-59.6%	0.000%
4/23/2024	Nations Financial Group Inc. IA ADV	6,757	$0.37M	0.0%	+9.7%	0.000%
4/23/2024	Gradient Investments LLC	4,944	$0.27M	0.0%	-52.8%	0.000%
4/23/2024	New Mexico Educational Retirement Board	102,534	$5.56M	0.2%	-6.2%	0.005%
4/23/2024	Sugarloaf Wealth Management LLC	2,671	$0.15M	0.0%	-17.9%	0.000%
4/23/2024	Wesbanco Bank Inc.	290,362	$15.75M	0.6%	+8.1%	0.014%
4/23/2024	Summit Trail Advisors LLC	16,343	$0.89M	0.0%	+40.6%	0.001%
4/23/2024	Regatta Capital Group LLC	7,245	$0.39M	0.1%	+3.9%	0.000%
4/23/2024	Principle Wealth Partners LLC	9,208	$0.50M	0.0%	+15.5%	0.000%
4/23/2024	Duncker Streett & Co. Inc.	52,163	$2.83M	0.6%	-6.9%	0.003%
4/23/2024	Loring Wolcott & Coolidge Fiduciary Advisors LLP MA	22,362	$1.21M	0.0%	-32.2%	0.001%
4/23/2024	Arcadia Investment Management Corp MI	8,491	$0.46M	0.1%	-78.3%	0.000%
4/23/2024	Cigna Investments Inc. New	21,512	$1.17M	0.2%	-1.2%	0.001%
4/23/2024	Hunter Perkins Capital Management LLC	55,975	$3.04M	0.6%	-4.8%	0.003%
4/23/2024	Strategic Blueprint LLC	17,293	$0.94M	0.1%	+78.0%	0.001%
4/23/2024	Accurate Wealth Management LLC	5,612	$0.30M	0.1%	+4.0%	0.000%
4/23/2024	Wealth Effects LLC	11,186	$0.61M	0.2%	-58.8%	0.001%
4/23/2024	Hanson & Doremus Investment Management	29,982	$1.63M	0.3%	-10.2%	0.001%
4/23/2024	Raymond James Financial Services Advisors Inc.	546,248	$29.62M	0.0%	-8.6%	0.027%
4/23/2024	Sutton Place Investors LLC	21,026	$1.14M	0.6%	+43.8%	0.001%
4/23/2024	Sapient Capital LLC	52,239	$2.83M	0.1%	-1.2%	0.003%
4/23/2024	Wendell David Associates Inc.	19,724	$1.07M	0.1%	-1.1%	0.001%
4/22/2024	Confluence Wealth Services Inc.	9,999	$0.54M	0.0%	-28.0%	0.000%
4/22/2024	Byrne Asset Management LLC	1,728	$94K	0.1%	-19.4%	0.000%
4/22/2024	Rovin Capital UT ADV	5,324	$0.29M	0.1%	N/A	0.000%
4/22/2024	Nilsine Partners LLC	9,739	$0.53M	0.1%	-4.4%	0.000%
4/22/2024	Harbour Trust & Investment Management Co	7,348	$0.40M	0.0%	-4.1%	0.000%
4/22/2024	PFG Investments LLC	73,075	$3.96M	0.2%	+352.7%	0.004%
4/22/2024	Sterling Investment Management LLC	20,343	$1.10M	0.8%	-2.1%	0.001%
4/22/2024	Altfest L J & Co. Inc.	26,449	$1.43M	0.2%	-0.9%	0.001%
4/22/2024	Parsons Capital Management Inc. RI	99,651	$5.40M	0.4%	-20.5%	0.005%
4/22/2024	Drive Wealth Management LLC	8,575	$0.47M	0.1%	+4.0%	0.000%
4/22/2024	Donaldson Capital Management LLC	639,855	$34.70M	1.4%	+5.5%	0.032%
4/22/2024	Raymond James & Associates	3,383,549	$183.49M	0.1%	+37.5%	0.167%
4/22/2024	Accordant Advisory Group Inc	580	$31K	0.0%	N/A	0.000%
4/22/2024	Lakewood Asset Management LLC	29,093	$1.58M	1.1%	+10.4%	0.001%
4/22/2024	Solitude Financial Services	6,000	$0.33M	0.1%	N/A	0.000%
4/22/2024	Investors Asset Management of Georgia Inc. GA ADV	7,746	$0.42M	0.2%	+22.9%	0.000%
4/22/2024	Arthur M. Cohen & Associates LLC	3,990	$0.22M	0.0%	N/A	0.000%
4/22/2024	IFM Investors Pty Ltd	440,663	$23.90M	0.3%	-1.3%	0.022%
4/22/2024	Everpar Advisors LLC	9,715	$0.53M	0.3%	-19.0%	0.000%
4/22/2024	Cassia Capital Partners LLC	11,779	$0.64M	0.4%	+45.5%	0.001%
4/22/2024	Ashton Thomas Private Wealth LLC	51,307	$2.78M	0.2%	+38.7%	0.003%
4/22/2024	Benchmark Financial Wealth Advisors LLC	16,528	$0.90M	0.3%	+8.4%	0.001%
4/20/2024	Maryland State Retirement & Pension System	159,870	$8.67M	0.2%	+0.9%	0.008%
4/20/2024	Cohen Investment Advisors LLC	7,132	$0.39M	0.3%	-2.8%	0.000%
4/19/2024	FORVIS Wealth Advisors LLC	25,824	$1.40M	0.0%	-4.7%	0.001%
4/19/2024	Everett Harris & Co. CA	12,770	$0.69M	0.0%	-3.4%	0.001%
4/19/2024	Marshall Financial Group LLC	28,437	$1.54M	0.4%	+8.1%	0.001%
4/19/2024	FCG Investment Co	8,212	$0.45M	0.4%	N/A	0.000%
4/19/2024	New Century Financial Group LLC	20,938	$1.14M	0.8%	N/A	0.001%
4/19/2024	Park Edge Advisors LLC	15,877	$0.86M	0.2%	-4.9%	0.001%
4/19/2024	Tempus Wealth Planning LLC	11,318	$0.61M	0.3%	+190.2%	0.001%
4/19/2024	Accel Wealth Management	4,934	$0.27M	0.1%	+19.0%	0.000%
4/19/2024	Legacy Wealth Asset Management LLC	9,860	$0.54M	0.1%	+5.9%	0.000%
4/19/2024	Uncommon Cents Investing LLC	10,305	$0.56M	0.2%	+13.9%	0.001%
4/19/2024	First Trust Direct Indexing L.P.	22,320	$1.21M	0.1%	+52.1%	0.001%
4/19/2024	Cornerstone Wealth Management LLC	15,392	$0.84M	0.1%	+6.6%	0.001%
4/19/2024	Kovack Advisors Inc.	30,489	$1.65M	0.2%	+32.4%	0.002%
4/19/2024	DMC Group LLC	6,597	$0.36M	0.3%	-3.5%	0.000%
4/19/2024	Hudson Capital Management LLC	68,494	$3.71M	1.3%	+10.7%	0.003%
4/19/2024	Abundance Wealth Counselors	26,690	$1.45M	0.3%	+26.9%	0.001%
4/19/2024	Westside Investment Management Inc.	6,761	$0.37M	0.1%	-5.5%	0.000%
4/19/2024	Norden Group LLC	236,606	$12.83M	0.1%	+2,125.2%	0.012%
4/19/2024	Arvest Investments Inc.	31,978	$1.73M	0.3%	-14.5%	0.002%
4/19/2024	Meadow Creek Wealth Advisors LLC	5,945	$0.32M	0.2%	+37.3%	0.000%
4/19/2024	Lake Street Private Wealth LLC	17,447	$0.95M	0.1%	+14.4%	0.001%
4/19/2024	Valley National Advisers Inc.	9,241	$0.50M	0.1%	-17.2%	0.000%
4/19/2024	E&G Advisors LP	5,551	$0.30M	0.1%	+5.7%	0.000%
4/19/2024	Redmont Wealth Advisors LLC	858	$47K	0.1%	N/A	0.000%
4/19/2024	State of Alaska Department of Revenue	502,222	$27.24M	0.3%	-8.6%	0.025%
4/19/2024	Albion Financial Group UT	1,985	$0.11M	0.0%	+60.0%	0.000%
4/19/2024	Carret Asset Management LLC	56,617	$3.07M	0.4%	-1.3%	0.003%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	5,074,466	$275.19M	0.2%	-9.3%	0.250%
4/18/2024	Plimoth Trust Co. LLC	31,677	$1.72M	0.5%	-1.4%	0.002%
4/18/2024	SeaCrest Wealth Management LLC	15,817	$0.86M	0.1%	-58.7%	0.001%

Data available starting January 2016

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $49.00

$48.96

$49.47

50 Day Range

MA: $51.22

$47.83

$54.40

52 Week Range

Now: $49.00

$47.58

$70.93

Volume

9,147,169 shs

Average Volume

15,525,874 shs

Market Capitalization

$99.31 billion

P/E Ratio

12.69

Dividend Yield

4.97%

Beta

0.39

Who are the company insiders with the largest holdings of Bristol-Myers Squibb?: Bristol-Myers Squibb's top insider shareholders include:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
David V Elkins (CFO)
Christopher S Boerner (CEO)
Rupert Vessey (EVP)
Ann Powell (EVP)
Theodore R Samuels II (Director)
Robert M Plenge (EVP)
Learn More about top insider investors at Bristol-Myers Squibb.
Who are the major institutional investors of Bristol-Myers Squibb?: Bristol-Myers Squibb's top institutional shareholders include:
Sumitomo Mitsui Trust Holdings Inc. — 0.25%
Raymond James & Associates — 0.17%
State of Michigan Retirement System — 0.09%
Los Angeles Capital Management LLC — 0.09%
Douglas Lane & Associates LLC — 0.09%
Allspring Global Investments Holdings LLC — 0.07%
Learn More about top institutional investors of Bristol-Myers Squibb stock.
Which institutional investors are selling Bristol-Myers Squibb stock?: During the last quarter, BMY stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
Gateway Investment Advisers LLC
Allspring Global Investments Holdings LLC
Moody Lynn & Lieberson LLC
Alaska Permanent Fund Corp
Los Angeles Capital Management LLC
Amalgamated Bank
Welch Group LLC
In the last year, company insiders that have sold Bristol-Myers Squibb company stock include:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
David V Elkins (CFO)
Learn More investors selling Bristol-Myers Squibb stock.
Which institutional investors are buying Bristol-Myers Squibb stock?: During the last quarter, BMY stock was purchased by institutional investors including:
State of Michigan Retirement System
Raymond James & Associates
Norden Group LLC
TB Alternative Assets Ltd.
Global Assets Advisory LLC
Miracle Mile Advisors LLC
Community Financial Services Group LLC
Wealth Enhancement Advisory Services LLC
During the last year, these company insiders have bought Bristol-Myers Squibb stock:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
Learn More investors buying Bristol-Myers Squibb stock.

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad